obesity Articles | Developments Today

How the 'holy grail' weight loss pill became a reality, and what comes next

GLP-1 Weight Loss Pills Arrive, Ushering In a New Era of Obesity Treatment

After years of development challenges, oral GLP-1 weight loss drugs are finally hitting the market. Novo Nordisk's oral Wegovy is already available, with Eli Lilly's orforglipron expected to win FDA approval soon.

Key Takeaways

Novo Nordisk's oral Wegovy is now available, with Lilly's orforglipron approval expected soon
Creating oral GLP-1 drugs required solving major absorption challenges with peptide molecules
The pill format could dramatically expand the $50 billion+ GLP-1 market to new patient populations

DE

DT Editorial AI·Mar 8, 2026·via statnews.com

AI Digital Twins Are Helping People Manage Diabetes and Obesity

Culture

How AI Digital Twins Are Revolutionizing Diabetes and Obesity Treatment

Silicon Valley startup Twin Health is using continuous sensor data and artificial intelligence to build virtual replicas of patients' metabolisms, creating personalized treatment plans that have helped thousands reduce medications and reverse type 2 diabetes symptoms.

Key Takeaways

Twin Health creates AI-powered digital replicas of patients' metabolisms using data from four wearable sensors
The system processes 3,000 daily data points to generate personalized nutrition and lifestyle recommendations
Clinical trials showed 89% of participants achieved target blood sugar levels while reducing medications
The company recently raised $53 million to expand its digital twin technology platform
The approach could help patients reduce dependence on costly GLP-1 drugs like Ozempic

DE

DT Editorial AI·Feb 17, 2026·via wired.com

Health

NTU Scientists Develop Gut-Based Compound That Blocks Fat Absorption Safely

An oral compound from NTU Singapore reduces intestinal fat uptake and promotes beneficial gut bacteria without toxic side effects in animal models.

Key Takeaways

NTU researchers develop an oral gut-based compound that blocks fat absorption without entering systemic circulation
The compound works by blocking intestinal fat receptors and promoting beneficial gut bacteria that produce short-chain fatty acids
Animal models showed less weight gain on high-fat diets, with a commercialization path starting as a supplement

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

#obesity

GLP-1 Weight Loss Pills Arrive, Ushering In a New Era of Obesity Treatment

How AI Digital Twins Are Revolutionizing Diabetes and Obesity Treatment

NTU Scientists Develop Gut-Based Compound That Blocks Fat Absorption Safely

GLP-1 Weight Loss Pills Arrive, Ushering In a New Era of Obesity Treatment

How AI Digital Twins Are Revolutionizing Diabetes and Obesity Treatment

NTU Scientists Develop Gut-Based Compound That Blocks Fat Absorption Safely